Euroapi S.A.S.U (EAPI) | Financial Analysis & Statements
Euroapi S.A.S.U. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
1.3B
Total Liabilities
516.5M
Shareholders Equity
788.2M
Debt to Equity
0.66
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2025
Euroapi S.A.S.U Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 852.6M | 919.2M | 1.0B | 980.9M | 892.8M |
| Cost of Goods Sold | 707.7M | 776.8M | 854.3M | 804.0M | 783.7M |
| Gross Profit | 144.8M | 142.4M | 164.6M | 176.9M | 109.1M |
| Gross Margin % | 17.0% | 15.5% | 16.2% | 18.0% | 12.2% |
| Operating Expenses | |||||
| Research & Development | 27.3M | 25.8M | 29.6M | 21.8M | 17.0M |
| Selling, General & Administrative | 115.8M | 127.0M | 130.9M | 128.2M | 89.4M |
| Other Operating Expenses | - | - | - | - | 5.4M |
| Total Operating Expenses | 143.1M | 152.8M | 160.5M | 150.0M | 111.8M |
| Operating Income | 1.7M | -10.2M | 4.5M | 27.1M | 1.5M |
| Operating Margin % | 0.2% | -1.1% | 0.4% | 2.8% | 0.2% |
| Non-Operating Items | |||||
| Interest Income | 700.0K | 6.0M | 800.0K | 8.2M | 200.0K |
| Interest Expense | 7.7M | 20.3M | 10.6M | 4.2M | 2.1M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -138.2M | -139.6M | -242.8M | 3.1M | -14.6M |
| Income Tax | 72.9M | -9.0M | -53.0M | 18.2M | -6.5M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 587.1% | 0.0% |
| Net Income | -211.2M | -130.6M | -189.7M | -15.1M | -8.1M |
| Net Margin % | -24.8% | -14.2% | -18.6% | -1.5% | -0.9% |
| Key Metrics | |||||
| EBITDA | 141.5M | 69.4M | 309.4M | 129.7M | 77.8M |
| EPS (Basic) | - | €-1.38 | €-2.02 | €-0.16 | €-0.09 |
| EPS (Diluted) | - | €-1.38 | €-2.02 | €-0.16 | €-0.09 |
| Basic Shares Outstanding | - | 94500000 | 94200000 | 93700000 | 94026888 |
| Diluted Shares Outstanding | - | 94500000 | 94200000 | 93700000 | 94026888 |
Income Statement Trend
Euroapi S.A.S.U Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 113.8M | 73.0M | 34.5M | 74.5M | 10.3M |
| Short-term Investments | 5.7M | 6.2M | 8.4M | 4.8M | 19.0M |
| Accounts Receivable | 114.9M | 161.3M | 216.2M | 264.2M | 238.9M |
| Inventory | 495.2M | 524.1M | 644.8M | 594.8M | 569.5M |
| Other Current Assets | - | 44.6M | 200.0K | -100.0K | 86.3M |
| Total Current Assets | 768.4M | 830.1M | 979.1M | 1.0B | 905.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 11.1M | 10.6M | 8.8M | 6.8M | 631.7M |
| Goodwill | 26.7M | 38.1M | 43.4M | 28.6M | 26.8M |
| Intangible Assets | 26.7M | 38.1M | 34.2M | 28.6M | 26.8M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 2.4M | 4.7M | 8.9M | 14.9M | 9.7M |
| Total Non-Current Assets | 536.3M | 659.2M | 633.1M | 712.5M | 717.0M |
| Total Assets | 1.3B | 1.5B | 1.6B | 1.7B | 1.6B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 110.5M | 104.9M | 159.6M | 219.6M | 189.6M |
| Short-term Debt | 49.1M | 55.9M | 210.0M | 104.6M | 5.4M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 17.9M | 2.3M | 9.8M | 10.0M | 191.7M |
| Total Current Liabilities | 295.2M | 311.5M | 509.1M | 456.4M | 386.7M |
| Non-Current Liabilities | |||||
| Long-term Debt | 16.3M | 13.2M | 15.5M | 16.2M | 18.7M |
| Deferred Tax Liabilities | 0 | 0 | 1.6M | 6.3M | 5.6M |
| Other Non-Current Liabilities | 54.4M | 16.8M | -200.0K | 100.0K | 100.0K |
| Total Non-Current Liabilities | 221.3M | 194.4M | 175.5M | 169.5M | 219.4M |
| Total Liabilities | 516.5M | 505.9M | 684.6M | 625.9M | 606.1M |
| Equity | |||||
| Common Stock | 95.6M | 95.6M | 95.1M | 94.6M | 90.0M |
| Retained Earnings | - | - | - | - | - |
| Treasury Stock | 2.0M | 2.0M | 1.9M | 1.3M | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 788.2M | 983.6M | 927.8M | 1.1B | 1.0B |
| Key Metrics | |||||
| Total Debt | 65.4M | 69.1M | 225.5M | 120.8M | 24.1M |
| Working Capital | 473.2M | 518.6M | 470.0M | 567.3M | 518.3M |
Balance Sheet Composition
Euroapi S.A.S.U Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -211.2M | -130.6M | -189.7M | -15.0M | -8.1M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | 1.8M |
| Working Capital Changes | 118.6M | 206.6M | -15.8M | -87.8M | -66.5M |
| Operating Cash Flow | -82.1M | 101.8M | -191.8M | -89.4M | -73.3M |
| Investing Activities | |||||
| Capital Expenditures | -77.0M | -108.0M | -132.8M | -167.4M | -87.9M |
| Acquisitions | - | 0 | -4.5M | 0 | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -77.0M | -108.0M | -137.3M | -167.4M | -87.9M |
| Financing Activities | |||||
| Share Repurchases | 0 | -100.0K | -600.0K | -1.3M | 0 |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 197.3M | 0 | - | - |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | -4.9M | 42.9M | 105.6M | 195.3M | 29.0M |
| Free Cash Flow | 50.0M | 14.9M | -127.7M | -122.6M | -17.1M |
| Net Change in Cash | -164.0M | 36.7M | -223.5M | -61.5M | -132.2M |
Cash Flow Trend
Euroapi S.A.S.U Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
8.84
Forward P/E
-10.00
Price to Book
0.20
Price to Sales
0.14
PEG Ratio
-10.00
Profitability Ratios
Profit Margin
-24.77%
Operating Margin
-2.24%
Return on Equity
-23.84%
Return on Assets
0.16%
Financial Health
Current Ratio
2.60
Debt to Equity
8.30
Beta
0.95
Per Share Data
EPS (TTM)
€-2.23
Book Value per Share
€6.18
Revenue per Share
€9.00
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| EAPI | 121.5M | 8.84 | 0.20 | -23.84% | -24.77% | 8.30 |
| Ipsen S.A | 13.4B | 30.83 | 3.12 | 10.44% | 11.29% | 22.38 |
| AB Science S.A | 76.8M | -7.73 | - | 32.97% | 116.42% | -0.80 |
| CoreTech Limited | 1.3M | - | - | -102.42% | 137.36% | -1.03 |
| Boiron S.A | 446.2M | 23.15 | 1.21 | 5.22% | 3.84% | 4.90 |
Financial data is updated regularly. All figures are in the company's reporting currency.